GO:0010595 positive regulation of endothelial cell migration: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0010595 describes any process that increases the frequency, rate or extent of endothelial cell migration, a central step in angiogenesis, vascular repair and tumor progression.
• Endothelial cell migration is driven by chemotactic, haptotactic and mechanical cues and is executed through cytoskeletal remodeling, focal adhesion turnover and extracellular matrix degradation.
• Key positive regulators include CELSR1, VEGFA, NF-κB signaling components, B7-H3, BACH1-regulated inflammatory pathways, COL1A1, ANGPTL4, SDC4, TREM2 and E-selectin [1,3,4,5,7,8].
• Dysregulated endothelial migration contributes to cancer angiogenesis, atherosclerosis, retinal neovascularization, remote lung injury and hepatic ischemia-reperfusion injury [1,2,3,4,6,7].
• CRISPR knockout, point mutation, knock-in and overexpression models enable causal dissection of genes that positively regulate endothelial cell migration.
• EDITGENE provides end-to-end CRISPR cell model generation and library screening to accelerate target validation in vascular biology and oncology.
Description
Endothelial cell migration is a fundamental biological process required for blood vessel formation, vascular remodeling and tissue repair. The Gene Ontology term GO:0010595, positive regulation of endothelial cell migration, captures any molecular event that increases the frequency, rate or extent of endothelial cell movement. This process is essential during embryonic development, wound healing and angiogenesis, and its dysregulation underpins numerous pathological conditions including cancer, cardiovascular disease and ischemia-reperfusion injury [1,2,3,6]. Researchers study GO:0010595 to identify pro-angiogenic factors, to understand how tumors co-opt vascular cells, and to discover therapeutic targets that modulate vascular growth [4,7]. The term encompasses signaling cascades initiated by growth factors, extracellular matrix components, inflammatory cytokines and mechanical forces, all converging on the cytoskeletal machinery that propels endothelial cells forward [5,8].
positive regulation of endothelial cell migration At A Glance
| GO ID | GO:0010595 |
|---|---|
| GO term | positive regulation of endothelial cell migration |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Upregulation of endothelial cell motility, essential for angiogenesis and vascular remodeling |
| Related processes | Angiogenesis, wound healing, tumor progression, inflammation [1,4,8] |
| Key regulators | CELSR1, VEGFA, NF-κB, B7-H3, BACH1, COL1A1, ANGPTL4, SDC4, TREM2, E-selectin [1,3,4,5,7,8] |
| Disease relevance | Cancer, atherosclerosis, retinal neovascularization, ischemia-reperfusion injury [1,2,3,4,6,7] |
What Is GO:0010595?
GO:0010595 (positive regulation of endothelial cell migration) is a biological process term that describes any process that activates or increases the frequency, rate or extent of endothelial cell migration. In practical terms, it includes the signaling events, gene expression changes and cytoskeletal rearrangements that promote the directed movement of endothelial cells, a key step in angiogenesis and vascular repair.
Why Is positive regulation of endothelial cell migration Important in Cell Biology?
Understanding positive regulation of endothelial cell migration is critical because this process is a rate-limiting step in angiogenesis, which supports tumor growth, metastasis and various ischemic and inflammatory diseases [1,4,7]. Modulating endothelial migration can either promote revascularization after injury or inhibit pathological neovascularization, making it a prime therapeutic target [2,6,8].
• Drives angiogenesis in cancer, supporting tumor growth and metastasis [1,4].
• Mediates vascular repair and regeneration after ischemia-reperfusion injury [2,6].
• Contributes to atherosclerotic plaque progression through endothelial inflammation.
• Underlies retinal neovascularization in ischemic retinopathies.
• Regulates neutrophil trafficking and remote lung injury via endothelial-derived vesicles.
• Involved in gastric cancer progression through endothelial-to-mesenchymal transition.
• Provides targets for anti-angiogenic therapy in oncology.
• Serves as a biomarker for vascular heterogeneity in liver injury.
• Modulated by cell adhesion molecules such as E-selectin in vascular pathophysiology.
• Enables high-throughput CRISPR screening to identify novel pro-migratory genes.
What Happens During positive regulation of endothelial cell migration?
Initiation by Chemotactic and Haptotactic Cues
In simple terms: Endothelial cells start moving when they receive signals from growth factors or matrix proteins.
Positive regulation of endothelial cell migration begins with the detection of pro-migratory signals such as vascular endothelial growth factor (VEGFA) or extracellular matrix components. For example, B7-H3 promotes colorectal cancer angiogenesis by activating NF-κB to induce VEGFA expression, which then stimulates endothelial cell migration. Similarly, CELSR1 acts as a positive regulator of endothelial cell migration and angiogenesis, likely through adhesion-dependent signaling.
Cytoskeletal Rearrangement and Focal Adhesion Turnover
In simple terms: The cell's internal skeleton reorganizes to push the cell forward and release attachments at the back.
Upon stimulation, endothelial cells undergo actin cytoskeletal remodeling, forming lamellipodia and filopodia that drive forward movement. Focal adhesion turnover allows the cell to detach from the rear and form new adhesions at the leading edge. CELSR1 has been shown to positively regulate endothelial cell migration, implicating adhesion GPCR signaling in cytoskeletal dynamics. E-selectin, an adhesion molecule, also modulates vascular pathophysiology and can influence endothelial migratory behavior.
Extracellular Matrix Remodeling and Proteolysis
In simple terms: Cells clear a path through the surrounding matrix by cutting proteins.
Migrating endothelial cells secrete proteases such as matrix metalloproteinases to degrade the extracellular matrix, creating space for movement. COL1A1-positive endothelial cells promote gastric cancer progression via the ANGPTL4-SDC4 axis driven by endothelial-to-mesenchymal transition, highlighting the role of matrix components in regulating migration. This remodeling is essential for sprouting angiogenesis.
Inflammatory and Immune Modulation
In simple terms: Inflammation can boost endothelial cell movement, but too much can cause damage.
Inflammatory signaling pathways positively regulate endothelial migration. Deletion of BACH1 attenuates atherosclerosis by reducing endothelial inflammation, indicating that BACH1 normally promotes pro-inflammatory and pro-migratory phenotypes. Endothelial cell-derived extracellular vesicles can also promote aberrant neutrophil trafficking and remote lung injury, linking endothelial migration to immune cell recruitment. M2 macrophage-derived migrasomes mediate ischemia-induced retinal neovascularization by targeting TREM2, further connecting immune signals to endothelial motility.
Resolution and Vessel Stabilization
In simple terms: Once cells reach their destination, they stop and form stable vessels.
After migration, endothelial cells align and form tubes, a process that requires a shift from migratory to quiescent phenotype. This step is critical for functional angiogenesis and is often dysregulated in disease. For instance, in hepatic ischemia-reperfusion injury, mitophagy-related genes and endothelial cell heterogeneity influence the resolution phase. Proper regulation ensures that vessel formation is balanced and pathological neovascularization is avoided.
Key Genes Involved in GO:0010595 positive regulation of endothelial cell migration
The following genes and proteins have been experimentally demonstrated to positively regulate endothelial cell migration in published studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CELSR1 | Adhesion GPCR that positively regulates endothelial cell migration and angiogenesis | Knockdown reduces migration; potential target for anti-angiogenic therapy |
| VEGFA | Key growth factor induced by NF-κB; promotes endothelial migration | Central to tumor angiogenesis; target of bevacizumab |
| B7-H3 | Immune checkpoint molecule that activates NF-κB to induce VEGFA | Promotes colorectal cancer angiogenesis; candidate for immunotherapy |
| BACH1 | Transcription factor that promotes endothelial inflammation | Deletion attenuates atherosclerosis; regulates pro-migratory genes |
| COL1A1 | Extracellular matrix protein; marks a subset of endothelial cells | Promotes gastric cancer progression via ANGPTL4-SDC4 axis |
| ANGPTL4 | Secreted protein involved in lipid metabolism and angiogenesis | Mediates endothelial-to-mesenchymal transition in gastric cancer |
| SDC4 | Syndecan proteoglycan that interacts with ANGPTL4 | Receptor for ANGPTL4; modulates endothelial migration |
| TREM2 | Immune receptor on macrophages; targeted by migrasomes | Mediates retinal neovascularization; potential target for retinopathies |
| E-selectin | Adhesion molecule expressed on activated endothelium | Modulates leukocyte-endothelial interactions and vascular pathophysiology |
| NF-κB | Transcription factor downstream of B7-H3 | Induces VEGFA; central to inflammatory angiogenesis |
| CXCR4 | Chemokine receptor for CXCL12 | Promotes endothelial migration in various contexts (implied by) |
| VEGFR2 | Receptor for VEGFA | Mediates pro-migratory signaling (implied by) |
| Integrin αvβ3 | Extracellular matrix receptor | Supports endothelial migration on vitronectin (implied by) |
| MMP2 | Matrix metalloproteinase | Degrades basement membrane during migration (implied by) |
| MMP9 | Matrix metalloproteinase | Facilitates matrix remodeling (implied by) |
| RhoA | Small GTPase | Regulates cytoskeletal dynamics during migration (implied by) |
| Rac1 | Small GTPase | Promotes lamellipodia formation (implied by) |
| Cdc42 | Small GTPase | Regulates filopodia formation (implied by) |
How Is positive regulation of endothelial cell migration Regulated?
Positive regulation of endothelial cell migration is controlled by a balance of pro- and anti-migratory signals. Key regulatory nodes include the NF-κB pathway, which induces VEGFA downstream of B7-H3, and the BACH1 transcription factor, whose deletion reduces endothelial inflammation and atherosclerosis. Inflammatory cytokines and extracellular vesicles can also modulate migration; endothelial cell-derived extracellular vesicles promote neutrophil trafficking and remote lung injury. Additionally, metabolic and mitophagy-related genes influence endothelial cell heterogeneity and migration in ischemia-reperfusion injury. The process is further fine-tuned by adhesion molecules such as E-selectin and by matrix-derived signals like COL1A1-ANGPTL4-SDC4.
positive regulation of endothelial cell migration and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| B7-H3 | Colorectal cancer angiogenesis | Knockout in HCT116 cells; tube formation assay |
| BACH1 | Atherosclerosis | Endothelial-specific knockout mouse; migration assay |
| COL1A1 | Gastric cancer progression | Knockdown in endothelial cells; co-culture with cancer cells |
| TREM2 | Retinal neovascularization | Knockout mouse; oxygen-induced retinopathy model |
| E-selectin | Vascular pathophysiology | Overexpression in HUVECs; leukocyte adhesion assay |
Cancer Angiogenesis and Metastasis
Positive regulation of endothelial cell migration is hijacked by tumors to promote angiogenesis. B7-H3 activates NF-κB to induce VEGFA, driving colorectal cancer angiogenesis. COL1A1-positive endothelial cells promote gastric cancer progression via the ANGPTL4-SDC4 axis and endothelial-to-mesenchymal transition. Targeting these pathways could inhibit tumor vascularization.
Atherosclerosis and Vascular Inflammation
Endothelial inflammation and migration contribute to atherosclerotic plaque formation. Deletion of BACH1 attenuates atherosclerosis by reducing endothelial inflammation, suggesting that BACH1 positively regulates pro-migratory and pro-inflammatory programs. E-selectin also plays a role in vascular pathophysiology, mediating leukocyte adhesion and endothelial activation.
Ischemia-Reperfusion Injury and Remote Organ Damage
Endothelial cell-derived extracellular vesicles promote aberrant neutrophil trafficking and remote lung injury, linking endothelial migration to inflammatory organ damage. In hepatic ischemia-reperfusion injury, mitophagy-related genes and endothelial cell heterogeneity influence injury outcomes. Modulating endothelial migration may protect against ischemia-reperfusion injury.
Retinal Neovascularization
M2 macrophage-derived migrasomes mediate ischemia-induced retinal neovascularization by targeting TREM2, highlighting a role for immune-endothelial crosstalk in pathological angiogenesis. Inhibiting endothelial migration could be therapeutic for retinopathies.
From positive regulation of endothelial cell migration-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X promote endothelial cell migration? | CRISPR knockout in HUVECs followed by scratch wound assay |
| Does a point mutation in gene Y affect migratory capacity? | Knock-in of point mutation using CRISPR in endothelial cells |
| Does overexpression of gene Z enhance angiogenesis? | Lentiviral overexpression in endothelial cells; tube formation assay |
| What is the role of gene W in tumor angiogenesis? | Endothelial-specific knockout mouse; tumor xenograft |
| Can a tagged version of protein V reveal its localization during migration? | CRISPR knock-in of GFP tag; live-cell imaging |
| Which genes regulate endothelial migration in a high-throughput manner? | Genome-wide CRISPR library screening in endothelial cells |
How to Study the positive regulation of endothelial cell migration Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Scratch wound assay | Rate of endothelial cell migration into a denuded area | Screening pro-migratory genes |
| Transwell migration assay | Number of cells migrating through a membrane | Quantifying chemotaxis |
| CRISPR knockout screen | Enrichment of sgRNAs in migrated vs. non-migrated cells | Identifying novel regulators |
| Live-cell imaging | Dynamics of cytoskeletal and adhesion proteins | Visualizing migration machinery |
| Tube formation assay | Ability of endothelial cells to form capillary-like structures | Assessing angiogenic potential |
| Western blot | Protein expression and phosphorylation | Validating signaling pathways |
| qPCR | mRNA levels of target genes | Confirming knockout or overexpression |
| Immunofluorescence | Localization of proteins in migrating cells | Studying focal adhesion dynamics |
CRISPR-Based Genetic Screens
Genome-wide CRISPR knockout or activation screens can identify positive regulators of endothelial cell migration. Cells are transduced with a library, selected, and subjected to a migration assay; enriched sgRNAs reveal candidate genes.
Migration Assays
Scratch wound healing and transwell migration assays are standard to quantify endothelial cell motility. These assays measure the rate of cell movement and can be combined with live-cell imaging to assess directionality.
Molecular Imaging and Proteomics
Live-cell imaging of fluorescently tagged cytoskeletal proteins (e.g., actin, focal adhesion kinase) reveals dynamic changes during migration. Proteomics can identify signaling complexes and post-translational modifications that regulate migration.
In Vivo Angiogenesis Models
Mouse models such as oxygen-induced retinopathy, tumor xenografts and hindlimb ischemia are used to study endothelial migration in a physiological context. Genetic manipulation via CRISPR enables causal testing of candidate genes [1,7].
How CRISPR Can Be Used to Study GO:0010595 positive regulation of endothelial cell migration
Knockout
CRISPR knockout of candidate genes in endothelial cells (e.g., HUVECs) is used to determine loss-of-function effects on migration. For example, knocking out CELSR1 reduces endothelial cell migration, confirming its positive regulatory role. Knockout models are essential for target validation in angiogenesis research.
Point Mutation
CRISPR-mediated point mutations can mimic disease-associated variants or disrupt specific phosphorylation sites. This allows researchers to dissect signaling domains required for pro-migratory functions without completely abolishing protein expression.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) or epitope tags enables real-time visualization of proteins during migration. Knock-in of reporter genes can also be used to monitor pathway activation in live cells.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can elevate gene expression to test sufficiency in promoting endothelial migration. Overexpression of VEGFA or B7-H3 enhances angiogenic phenotypes in cancer models.
How EDITGENE Supports positive regulation of endothelial cell migration Research
Researchers studying positive regulation of endothelial cell migration-related genes often need to determine whether a candidate gene is causally involved in promoting or inhibiting endothelial motility. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models, enabling rigorous functional validation.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of endothelial cell migration research.
Frequently Asked Questions About positive regulation of endothelial cell migration
What is GO:0010595?
GO:0010595 is the Gene Ontology term for positive regulation of endothelial cell migration, describing any process that increases the frequency, rate or extent of endothelial cell movement.
What genes are involved in positive regulation of endothelial cell migration?
Key genes include CELSR1, VEGFA, B7-H3, BACH1, COL1A1, ANGPTL4, SDC4, TREM2 and E-selectin, among others [1,3,4,5,7,8].
How is endothelial cell migration regulated?
It is regulated by chemotactic signals, inflammatory pathways (e.g., NF-κB), adhesion molecules and matrix remodeling, with BACH1 and B7-H3 as critical modulators [3,4].
Why is endothelial cell migration important in cancer?
Tumors induce endothelial cell migration to form new blood vessels, supporting growth and metastasis; targeting this process can inhibit tumor angiogenesis [1,4].
What diseases are associated with abnormal endothelial cell migration?
Cancer, atherosclerosis, retinal neovascularization, ischemia-reperfusion injury and remote lung injury are linked to dysregulated endothelial migration [1,2,3,6,7].
What methods are used to study positive regulation of endothelial cell migration?
Common methods include scratch wound assays, transwell migration, CRISPR screens, live-cell imaging and in vivo angiogenesis models.
How can CRISPR help study endothelial cell migration?
CRISPR knockout, point mutation, knock-in and overexpression allow causal testing of genes in endothelial cells, revealing their role in migration.
What is the role of CELSR1 in endothelial cell migration?
CELSR1 is a positive regulator of endothelial cell migration and angiogenesis; its knockdown reduces migratory capacity.
How does B7-H3 promote angiogenesis?
B7-H3 activates NF-κB to induce VEGFA expression, which stimulates endothelial cell migration and angiogenesis in colorectal cancer.
What is the connection between BACH1 and atherosclerosis?
Deletion of BACH1 attenuates atherosclerosis by reducing endothelial inflammation, indicating BACH1 promotes pro-inflammatory and pro-migratory phenotypes.
Conclusion
GO:0010595, positive regulation of endothelial cell migration, is a central biological process in angiogenesis, vascular repair and disease. Its dysregulation contributes to cancer, atherosclerosis, retinal neovascularization and ischemia-reperfusion injury. Understanding the genes and signaling pathways that positively regulate endothelial migration offers therapeutic opportunities. CRISPR-based models and screening technologies are powerful tools to dissect these mechanisms and identify new drug targets.
References
- 1. Liu Q et al.. 2025. COL1A1-positive endothelial cells promote gastric cancer progression via the ANGPTL4-SDC4 axis driven by endothelial-to-mesenchymal transition.. Cancer Lett 623:217731 PMID: 40254092
- 2. Zi SF et al.. 2024. Endothelial Cell-Derived Extracellular Vesicles Promote Aberrant Neutrophil Trafficking and Subsequent Remote Lung Injury.. Adv Sci (Weinh) 11(38):e2400647 PMID: 39119837
- 3. Jia M et al.. 2022. Deletion of BACH1 Attenuates Atherosclerosis by Reducing Endothelial Inflammation.. Circ Res 130(7):1038-1055 PMID: 35196865
- 4. Wang R et al.. 2020. B7-H3 promotes colorectal cancer angiogenesis through activating the NF-κB pathway to induce VEGFA expression.. Cell Death Dis 11(1):55 PMID: 31974361
- 5. Zhan YH et al.. 2016. CELSR1 Is a Positive Regulator of Endothelial Cell Migration and Angiogenesis.. Biochemistry (Mosc) 81(6):591-9 PMID: 27301287
- 6. Pan B et al.. 2024. Predicting mitophagy-related genes and unveiling liver endothelial cell heterogeneity in hepatic ischemia-reperfusion injury.. Front Immunol 15:1370647 PMID: 38694511
- 7. Li B et al.. 2025. M2 Macrophage-Derived Migrasomes Mediate Ischaemia-Induced Retinal Neovascularization by Targeting TREM2.. J Extracell Vesicles 14(11):e70180 PMID: 41170761
- 8. Zhang J et al.. 2024. E-selectin in vascular pathophysiology.. Front Immunol 15:1401399 PMID: 39100681
